|
1
|
Yip KM, Leung PC and Kumta SM: Giant cell
tumor of bone. Clin Orthop Relat Res. 323:60–64. 1996. View Article : Google Scholar
|
|
2
|
Leung KH, Lam AY, Ho KW and Shek TW: Giant
cell tumor of the humeral head treated by denosumab: Implication to
shoulder surgeons. Int J Shoulder Surg. 9:135–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng MH, Robbins P, Xu J, Huang L, Wood D
and Papadimitriou J: The histogenesis of giant cell tumour of bone:
a model of interaction between neoplastic cells and osteoclasts.
Histol Histopathol. 16:297–307. 2001.PubMed/NCBI
|
|
4
|
Sobti A, Agrawal P, Agarwala S and Agarwal
M: Giant cell tumor of bone - An overview. Arch Bone Jt Surg.
4:2–9. 2016.PubMed/NCBI
|
|
5
|
James IE, Walsh S, Dodds RA and Gowen M:
Production and characterization of osteoclast-selective monoclonal
antibodies that distinguish between multinucleated cells derived
from different human tissues. J Histochem Cytochem. 39:905–914.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang L, Teng XY, Cheng YY, Lee KM and
Kumta SM: Expression of preosteoblast markers and Cbfa-1 and
Osterix gene transcripts in stromal tumour cells of giant cell
tumour of bone. Bone. 34:393–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Razinia Z, Mäkelä T, Ylänne J and
Calderwood DA: Filamins in mechanosensing and signaling. Annu Rev
Biophys. 41:227–246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeon GW, Lee MN, Jung JM, Hong SY, Kim YN,
Sin JB and Ki CS: Identification of a de novo heterozygous missense
FLNB mutation in lethal atelosteogenesis type I by exome
sequencing. Ann Lab Med. 34:134–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura F, Stossel TP and Hartwig JH: The
filamins: Organizers of cell structure and function. Cell Adhes
Migr. 5:160–169. 2011. View Article : Google Scholar
|
|
10
|
Popowicz GM, Schleicher M, Noegel AA and
Holak TA: Filamins: Promiscuous organizers of the cytoskeleton.
Trends Biochem Sci. 31:411–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stossel TP: Filamins and the potential of
complexity. Cell Cycle. 9:14632010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gorlin JB, Yamin R, Egan S, Stewart M,
Stossel TP, Kwiatkowski DJ and Hartwig JH: Human endothelial
actin-binding protein (ABP-280, nonmuscle filamin): A molecular
leaf spring. J Cell Biol. 111:1089–1105. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pudas R, Kiema TR, Butler PJ, Stewart M
and Ylänne J: Structural basis for vertebrate filamin dimerization.
Structure. 13:111–119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sawyer GM and Sutherland-Smith AJ: Crystal
structure of the filamin N-terminal region reveals a hinge between
the actin binding and first repeat domains. J Mol Biol.
424:240–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakamura F, Osborn TM, Hartemink CA,
Hartwig JH and Stossel TP: Structural basis of filamin A functions.
J Cell Biol. 179:1011–1025. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu W, Xie Z, Chung DW and Davie EW: A
novel human actin-binding protein homologue that binds to platelet
glycoprotein Ibalpha. Blood. 92:1268–1276. 1998.PubMed/NCBI
|
|
17
|
Dalkilic I, Schienda J, Thompson TG and
Kunkel LM: Loss of FilaminC (FLNc) results in severe defects in
myogenesis and myotube structure. Mol Cell Biol. 26:6522–6534.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van der Flier A, Kuikman I, Kramer D,
Geerts D, Kreft M, Takafuta T, Shapiro SS and Sonnenberg A:
Different splice variants of filamin-B affect myogenesis,
subcellular distribution, and determine binding to integrin [beta]
subunits. J Cell Biol. 156:361–376. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Giancotti FG and Ruoslahti E: Integrin
signaling. Science. 285:1028–1032. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lau CP, Ng PK, Li MS, Tsui SK, Huang L and
Kumta SM: p63 regulates cell proliferation and cell cycle
progression associated genes in stromal cells of giant cell tumor
of the bone. Int J Oncol. 42:437–443. 2013.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu PF, Tang JY and Li KH: RANK pathway in
giant cell tumor of bone: Pathogenesis and therapeutic aspects.
Tumour Biol. 36:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang T, Yin H, Wang J, Li Z, Wei H, Liu Z,
Wu Z, Yan W, Liu T, Song D, et al: MicroRNA-106b inhibits
osteoclastogenesis and osteolysis by targeting RANKL in giant cell
tumor of bone. Oncotarget. 6:18980–18996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lau CP, Huang L, Tsui SK, Ng PK, Leung PY
and Kumta SM: Pamidronate, farnesyl transferase, and geranylgeranyl
transferase-I inhibitors affects cell proliferation, apoptosis, and
OPG/RANKL mRNA expression in stromal cells of giant cell tumor of
bone. J Orthop Res. 29:403–413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang L, Cheng YY, Chow LT, Zheng MH and
Kumta SM: Tumour cells produce receptor activator of NF-kappaB
ligand (RANKL) in skeletal metastases. J Clin Pathol. 55:877–878.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong SS, Liu XG, Chen Y, Guo Y, Wang L,
Zhao J, Xiong DH, Xu XH, Recker RR and Deng HW: Association
analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck
compression strength index variation in Caucasians. Calcif Tissue
Int. 85:104–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Q, Jiang Z, Meng T, Yin H, Wang J,
Wan W, Cheng M, Yan W, Liu T, Song D, et al: MiR-30a inhibits
osteolysis by targeting RunX2 in giant cell tumor of bone. Biochem
Biophys Res Commun. 453:160–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Neve A, Corrado A and Cantatore FP:
Osteocalcin: Skeletal and extra-skeletal effects. J Cell Physiol.
228:1149–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang L, Xu J, Wood DJ and Zheng MH: Gene
expression of osteoprotegerin ligand, osteoprotegerin, and receptor
activator of NF-kappaB in giant cell tumor of bone: Possible
involvement in tumor cell-induced osteoclast-like cell formation.
Am J Pathol. 156:761–767. 2000. View Article : Google Scholar : PubMed/NCBI
|
